Short answer
ACME UNITED CORP (ACU) filed an 8-K current report with the SEC on October 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results released for the quarter ended September 30, 2026.
ACME UNITED CORP 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 results released for the quarter ended September 30, 2026
- Financial details and management commentary contained in Exhibit 99.1 press release
Item EX-99.1 · Exhibit EX-99.1
- Q3 net sales $58.0M, up 18%, with 10% comparable growth excluding My Medic acquisition contribution
- Net income $3.4M, up 80%, and diluted EPS $0.80 versus $0.46, supported by stronger sales and tariff refunds
- Gross margin 45.3% versus 39.1%, including 690 basis points from $4.0M recognized tariff refunds
- DMT closure costs reduced gross margin by 310 basis points, with annual savings expected to exceed $1.0M in 2027
- Net debt increased to $29.7M after $14.5M My Medic acquisition spending, $2.4M dividends and $1.6M German product-line purchase
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACME UNITED CORP 8-K filings
Get the next ACU 8-K as it lands
Follow ACU for push alerts, or ask the research agent what this filing means.